NCT06431594 - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors | Biotech Hunter

Enrollment

385

Participants

Timeline

Start Date

July 2, 2024

Primary Completion Date

February 1, 2027

Study Completion Date

September 20, 2027

Conditions

Solid TumorsNeoplasms

Interventions

DRUG

GSK5733584

GSK5733584 will be administered

Trial Locations (47)

1118

RECRUITING

GSK Investigational Site, Ciudad de Buenos Aires

2109

RECRUITING

GSK Investigational Site, Macquarie University

2148

RECRUITING

GSK Investigational Site, Blacktown

3000

RECRUITING

GSK Investigational Site, Leuven

10408

RECRUITING

GSK Investigational Site, Gyeonggi-do

14004

RECRUITING

GSK Investigational Site, Córdoba

17007

RECRUITING

GSK Investigational Site, Girona

17164

RECRUITING

GSK Investigational Site, Stockholm

20089

RECRUITING

GSK Investigational Site, Rozzano MI

28027

RECRUITING

GSK Investigational Site, Madrid

28034

RECRUITING

GSK Investigational Site, Madrid

28040

RECRUITING

GSK Investigational Site, Madrid

28046

RECRUITING

GSK Investigational Site, Madrid

28223

RECRUITING

GSK Investigational Site, Pozuelo de AlarcOn Madr

32746

RECRUITING

GSK Investigational Site, Lake Mary

33520

RECRUITING

GSK Investigational Site, Tampere

37203

RECRUITING

GSK Investigational Site, Nashville

44805

RECRUITING

GSK Investigational Site, Saint-Herblain

48201

RECRUITING

GSK Investigational Site, Detroit

49546

RECRUITING

GSK Investigational Site, Grand Rapids

66205

RECRUITING

GSK Investigational Site, Fairway

69373

RECRUITING

GSK Investigational Site, Lyon

75230

RECRUITING

GSK Investigational Site, Dallas

84119

RECRUITING

GSK Investigational Site, West Valley City

94805

RECRUITING

GSK Investigational Site, Villejuif

02114

RECRUITING

GSK Investigational Site, Boston

02215

RECRUITING

GSK Investigational Site, Boston

R8324CVE

RECRUITING

GSK Investigational Site, Cipoletti Rio Negro

S2002

RECRUITING

GSK Investigational Site, Rosario

K1H 8L6

RECRUITING

GSK Investigational Site, Ottawa

M5G 2M9

RECRUITING

GSK Investigational Site, Toronto

H2X 0A9

RECRUITING

GSK Investigational Site, Montreal

00180

RECRUITING

GSK Investigational Site, Helsinki

00290

RECRUITING

GSK Investigational Site, Helsinki

00168

RECRUITING

GSK Investigational Site, Roma

350-1298

RECRUITING

GSK Investigational Site, Saitama

411-8777

RECRUITING

GSK Investigational Site, Shizuoka

135-8550

RECRUITING

GSK Investigational Site, Tokyo

1066 CX

RECRUITING

GSK Investigational Site, Amsterdam

03080

RECRUITING

GSK Investigational Site, Seoul

03722

RECRUITING

GSK Investigational Site, Seoul

06351

RECRUITING

GSK Investigational Site, Seoul

08035

RECRUITING

GSK Investigational Site, Barcelona

SE-751 85

RECRUITING

GSK Investigational Site, Uppsala

CB2 0QQ

RECRUITING

GSK Investigational Site, Cambridge

NW1 2PG

RECRUITING

GSK Investigational Site, London

W1G 6AD

RECRUITING

GSK Investigational Site, London